20
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T8767 |
PfDHODH-IN-2
|
Dehydrogenase; Parasite | Metabolism; Microbiology/Virology |
PfDHODH-IN-2 是一种二氢噻吩酮衍生物,是一种有效的恶性疟原虫二氢乳清酸脱氢酶抑制剂,其IC50值为 1.11 µM。它具有抗疟作用,可研究疟疾。 | |||
T10903 |
CWHM-1552
|
Parasite | Microbiology/Virology |
CWHM-1552 是一种有效的恶性疟原虫抑制剂。 对于 3D7 和 Dd2 菌株,IC50 分别为 51 nM 和 53 nM。 | |||
T12154L |
N-Desethyl amodiaquine dihydrochloride
|
Parasite | Microbiology/Virology |
N-Desethyl amodiaquine dihydrochloride 是一种抗寄生虫剂,是主要的生物活性阿莫地喹代谢物。它对菌株 V1/S 和 3D7 的 IC50值分别为 97 nM 和 25 nM。 | |||
T9741 |
INE963
|
Others | Others |
INE963 是快速有效的血液阶段抗疟剂,EC50为 3-6 nM。INE963 有单纯性疟疾的研究潜力。 | |||
T10902 |
CWHM-1008
|
Others | Others |
CWHM-1008 is an effective oral antimalarial drug. The EC50 values of the drug-sensitive Plasmodium falciparum 3D7 and drug-resistant Dd2 strains are 46 and 21 nM, respectively. | |||
T63413 |
Antimalarial agent 15
|
||
Antimalarial agent 15 是 parasite 抑制剂,表现出抗疟作用,对恶性疟原虫 3D7 的生长具有抑制作用,其 IC50值为20 nM。 | |||
T12154 |
N-Desethyl amodiaquine
|
Parasite | Microbiology/Virology |
N-Desethyl amodiaquine 是一种抗寄生虫剂,是主要的生物活性阿莫地喹代谢物。它对菌株 V1/S 和 3D7 的 IC50值分别为 97 nM 和 25 nM。 | |||
T71619 | ST72 | ||
ST72 is a potent inhibitor of FP2. ST72 exhibited strong growth inhibition of chloroquine-sensitive (3D7; EC50 = 2.8 µM) and chloroquine-resistant (RKL-9; EC50 = 6.7 µM) strains of Plasmodium falciparum | |||
T61971 |
CHMFL-PI4K-127
|
||
CHMFL-PI4K-127 (compound 15g) 是具有口服活性、高选择性的PfPI4K(恶性疟原虫 PI4K 激酶)抑制剂(IC50= 0.9 nM)。CHMFL-PI4K-127 对 3D7 恶性疟原虫表现出较强的抑制活性(EC50= 25.1 nM)。CHMFL-PI4K-127 具有抗疟疾作用。 | |||
T61047 | JMI-346 | ||
JMI-346 可用作抗疟疾剂,可抑制恶性疟原虫菌株的 CQS (3D7) 和 CQR (RKL-9) 菌株生长,IC50 值分别为 13 μM 和 33 μM。JMI-346 是恶性疟原虫 -2 蛋白酶(PfFP-2)的有效抑制剂。 | |||
T15173 |
DSM265
PfSPZ |
Dehydrogenase; Parasite | Metabolism; Microbiology/Virology |
DSM265 (PfSPZ) 是一种具有抗疟活性的二氢乳清酸脱氢酶抑制剂(IC50:8.9 nM)。DSM265 抑制 Pf3D7 寄生虫的生长可用于治疗和预防疟疾感染。 | |||
T78184 |
MMV009085
|
||
MMV009085是一种针对恶性疟原虫己糖转运体PfHT1的特异性抑制剂,具有潜在的抗疟效果。它同时抑制人葡萄糖转运蛋白,强效抑制葡萄糖吸收(IC50:2.6 μM)及恶性疟原虫3D7株的生长(EC50:1.23±0.04 μM)。 | |||
T61058 | JMI-105 | ||
JMI-105 具有用作抗疟剂的潜力。JMI-105 是恶性疟原虫 -2 蛋白酶(PfFP-2)的有效抑制剂,可抑制恶性疟原虫菌株的CQS 株 (3D7) 和 CQR 株 (RKL-9) 的生长,IC50值分别为8.8 μM 和14.3 μM。在伯氏疟原虫 ANKA 感染小鼠模型中,JMI-105 显著降低寄生虫血症并延长宿主存活期。 | |||
T63456 |
Antimalarial agent 12
|
||
Antimalarial agent 12 是有效的抗疟 (antimalarial) 药,能够抑制恶性疟原虫 Dd2 菌株、3D7 菌株生长,其 EC50值分别为155 nM、136 nM。Antimalarial agent 12 对大肠杆菌的 MIC>250,000 nM,也能够作用于 HEK-293 和 hPHep 细胞系,其 CC50值为 10,000-50,000 nM。 | |||
T38269 | Purfalcamine | ||
Purfalcamine is an orally active, selective Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1) inhibitor with an IC50 of 17 nM and an EC50 of 230 nM. Purfalcamine has antimalarial activity and causes malaria parasites developmental arrest at the schizont stage[1][2]. Purfalcamine has low activity against Toxoplasma gondii calcium-dependent protein kinase 3 (TgCDPK3)[1]. Purfalcamine (225, 450 nM) has no effect on the parasitemia in the first 32 hours. After about 40 hours, paras... | |||
T11039 |
Didesethyl chloroquine
Bisdesethylchloroquine |
Drug Metabolite | Metabolism |
Didesethyl chloroquine (Bisdesethylchloroquine) 是一种有效的心肌抑制剂。Didesethyl chloroquine 是抗疟药氯喹的主要代谢产物。 | |||
T36649 | AN3661 | ||
AN3661, a potent antimalarial lead compound, targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue subunit 3 (PfCPSF3). AN3661 inhibits Plasmodium falciparum laboratory-adapted strains, Ugandan field isolates, and murine P. berghei and P. falciparum infections[1]. AN3661 is active at nanomolar (IC50=20-56 nM) concentrations against P. falciparum laboratory strains known to be sensitive (3D7) or resistant (W2, Dd2, K1, HB3, FCR3 and TM90C2B), and AN3661 is simi... | |||
T12838 |
SARS-CoV-IN-2
|
Others | Others |
SARS-CoV-IN-2 is an effective SARS-CoV replication inhibitor | |||
T12837 | SARS-CoV-IN-1 | Others | Others |
SARS-CoV-IN-1 is an effective SARS-CoV replication inhibitor(EC50 of 4.9 μM in Vero cells). | |||
T12839 |
SARS-CoV-IN-3
|
Others | Others |
SARS-CoV-IN-3 is an effective SARS-CoV replication inhibitor. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TQ0072 |
Warangalone
Scandenolone,攀登鱼藤异黄酮 |
PKA | Tyrosine Kinase/Adaptors |
Warangalone is an anti-malarial compound that can inhibit the growth of both strains of parasite 3D7 (chloroquine-sensitive) and K1 (chloroquine-resistant) with IC50s of 4.8 μg/mL and 3.7 μg/mL, respectively. | |||
T2S2362 |
Dehydrocorydaline nitrate
去氢延胡索甲素硝酸盐,硝酸脱氢紫堇碱 |
BCL; Others; PARP; p38 MAPK; Caspase; Parasite; Autophagy | Apoptosis; Autophagy; Chromatin/Epigenetic; DNA Damage/DNA Repair; MAPK; Microbiology/Virology; Others; Proteases/Proteasome |
Dehydrocorydaline nitrate 是生物碱。Dehydrocorydaline 调节 Bax,Bcl-2蛋白表达,激活 caspase-7,caspase-8,并使 PARP 失活。它能增强 p38 MAPK 活化,具有抗炎、抗癌、抗疟疾等功效。 | |||
TN4449 |
Longistylin C
|
Antifection | Microbiology/Virology |
Longistylin A and longistylin C show some cytotoxic effects, with IC(50) values of 0.7-14.7 microM against the range of cancer cell lines. Longistylin A and longistylin C, and betulinic acid show a moderately high in vitro activity against the chloroquine |